ClinicalTrials.gg
Not yet recruitingNCT07875387Updated Oct 15, 2026

Effect of Bioactive Glass Varnish on Salivary Parameters in Children: Randomized Controlled Trial

An interventional study of Bioactive glass topical varnish and Fluoride varnish in Prevention of Dental Caries, sponsored by Pharos University in Alexandria. Not yet recruiting. Open to participants aged 6 Months to 12 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Pharos University in Alexandria · Not applicable, Interventional, and Prevention

Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
6 Months to 12 Months
Sex
All
01

Study summary

This study is a two-arm parallel randomized controlled trial led by Principal Investigator Inas Karawia at the Faculty of Dentistry, designed to evaluate and compare the short-term (immediatly) and sustained (over 6 months) effects of a single application of bioactive glass varnish versus traditional fluoride varnish on salivary parameters in healthy children aged 6-12 years with normal salivary flow and no active caries. Unstimulated morning saliva samples (collected between 9:00-11:00 AM) will be assessed at baseline, 1 week, and 1 month to evaluate changes in salivary pH (via a calibrated digital pH meter), flow rate (in mL/min over 5 minutes), and Streptococcus mutans bacterial counts (in CFU/mL via culturing on Mitis Salivarius Bacitracin agar). With sample size determined using G*Power software to ensure 80% statistical power \& alpha = 0.05), the collected longitudinal data across both groups will be analyzed using Two-Way Repeated Measures ANOVA and student t test between the 2 groups in SPSS to detect significant differences over time and between treatments.

Read the detailed description

Bioactive glass is a biomaterial of interest in preventive dentistry because of its interaction with the oral environment and its potential to release mineral ions. Fluoride varnish is an established preventive dental material, while bioactive glass varnish represents an alternative material whose effects on salivary characteristics require further clinical evaluation. Saliva contributes to oral homeostasis through its buffering capacity, lubrication, and clearance functions. Salivary pH and flow rate are relevant indicators of the oral environment, while Streptococcus mutans is associated with the development of dental caries.

This randomized controlled clinical trial will compare the effects of a single application of bioactive glass varnish with those of fluoride varnish in children. The study is designed to assess changes in selected salivary parameters over a six-month follow-up period, including both an early assessment and a later assessment following treatment.

Unstimulated saliva samples will be collected at baseline before varnish application and at the scheduled follow-up visits. Collection will take place between 9:00 and 11:00 a.m. to maintain consistency in sampling conditions. Salivary pH will be measured using a calibrated digital pH meter. Salivary flow rate will be calculated from the volume of unstimulated saliva collected over five minutes. Salivary Streptococcus mutans levels will be determined by microbiological culture on Mitis Salivarius Bacitracin agar, with bacterial counts expressed as colony-forming units per milliliter.

The longitudinal measurements will be evaluated to examine changes in salivary parameters over time and differences between the two treatment groups. The findings will provide comparative clinical data on the effects of bioactive glass varnish and fluoride varnish on selected salivary parameters in children and may help inform further research into bioactive materials for preventive dental care.

02

Conditions studied

  • Prevention of Dental Caries

Browse trials for

Keywords

  • Bioactive glass varnish
  • Fluoride varnish
  • Salivary Streptococcus mutans
03

In context

Dental Caries

1,171 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 967 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Pharos University in Alexandria is the lead sponsor of 22 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 12 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy children with no active dental caries or oral lesions
  • Normal salivary flow rate
  • Willingness to participate

Exclusion criteria

Exclusion Criteria:

    • History of systemic illness or medication affecting salivary secretion

      • Recent use (within 1 month) of antibiotics, mouthwash, or fluoride varnish
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    fluoride varnish

    Other: Bioactive glass topical varnish

  • Experimental
    Bioactive glass varnish

    Other: Fluoride varnish

Interventions

  • OtherBioactive glass topical varnish

    topical preventive measure to resist dental caries

  • OtherFluoride varnish

    traditional preventive measure to dental caries

06

What researchers measure

Primary outcomes

  1. Change in Salivary Streptococcus mutans Count from Baseline (CFU/mL)

    Time frame: 6 months

  2. Change in Unstimulated Salivary Flow Rate from Baseline

    Time frame: 6 months

  3. Change in Unstimulated Salivary pH from Baseline

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 2 months is below that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 15, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07875387
Lead sponsor
Pharos University in Alexandria
Responsible party
Inas Mahmoud Karawia (Lecturer of dental public health and preventive dentistry, Pharos University in Alexandria) — Principal investigator
First posted
Oct 15, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Oct 15, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion